12:00 AM
Nov 23, 2009
 |  BC Week In Review  |  Company News  |  Deals

Addrenex, Shionogi deal

Shionogi's Sciele Pharma Inc. subsidiary will acquire partner Addrenex for about $29 million in cash. Sciele already has rights to Addrenex's Clonicel clonidine to treat ADHD, Jenloga...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >